Skip to main content
Mandeep Mehra, MD, Cardiology, Boston, MA

MandeepRajinderMehraMD

Cardiology Boston, MA

Heart Failure & Transplantation, Interventional Cardiology, Cardiac Critical Care

The William Harvey Distinguished Chair in Cardiovascular Medicine, Executive Director of the Center for Advanced Heart Disease, Brigham and Women’s Hospital; Professor of Medicine at Harvard Medical School; Editor-in-Chief Emeritus, The Journal of Heart and Lung Transplantation

Dr. Mehra is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mehra's full profile

Already have an account?

  • Office

    BWH - Cardiovascular Medicine
    75 Francis Street, A-324
    Boston, MA 02115
    Phone+1 617-732-8534
    Fax+1 617-264-5265

Summary

  • Dr. Mehra is the William Harvey Distinguished Chair in Advanced Cardiovascular Medicine at Brigham and Women’s Hospital and a Professor of Medicine at Harvard Medical School; He also served as Editor-in-Chief, The Journal of Heart and Lung Transplantation from 2010-2020.

    Prior to joining the Brigham and Women’s Hospital, Dr. Mehra served as the Dr. Herbert Berger Endowed Professor of Medicine and Head of Cardiology as well as Assistant Dean for Clinical Services at the University of Maryland School of Medicine. Dr. Mehra has authored and published over 500 book chapters, manuscripts, editorials and abstracts focusing on all aspects of advanced heart failure and cardiac transplantation, treatment modalities, medical therapies and alternatives to transplantation. His specific research interests in cardiac transplantation focus on cardiac allograft vasculopathy (use of intravascular ultrasound and angioscopy), new immunosuppressive therapy to improve heart transplant outcomes (particularly in minority populations), and in bringing genomic and proteomic science to the bedside (to avoid the morbidity of endomyocardial biopsies).

    In Heart Failure, his research has focused on the role of novel cardiac support devices and serum markers to guide diagnosis and therapy. One important area of his focus is in developing international guidelines for care of the heart transplant candidate and process enhancement for improving performance measure adherence in heart failure. Dr. Mehra is a Past-President of the International Society of Heart and Lung Transplantation (ISHLT, 2008) and the Heart Failure Society of America (HFSA, 2016). His current research is focussed on mechanical circulatory support and featured in journals such as the New England Journal of Medicine. He has a certificate in executive leadership from Harvard Business School. He also has a healthcare economic Masters degree from the London School of Economics, which he attained as the "Braunwald Scholar".

Education & Training

  • London School of Economics
    London School of EconomicsMSc, Healthcare Economics and Management, 2016 - 2018
  • Harvard University
    Harvard UniversityA.M, Honorary, 2012 - 2012
  • Harvard University
    Harvard UniversityAM, Honorary, 2012
  • Ochsner Clinic Foundation
    Ochsner Clinic FoundationFellowship, Cardiovascular Disease, 1992 - 1995
  • Mount Carmel Health System
    Mount Carmel Health SystemResidency, Internal Medicine, 1989 - 1992
  • Mahatma Gandhi Institute of Medical Science
    Mahatma Gandhi Institute of Medical ScienceClass of 1987

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2012 - 2024
  • MD State Medical License
    MD State Medical License 2005 - 2015
  • OH State Medical License
    OH State Medical License 1992 - 2012
  • LA State Medical License
    LA State Medical License 1992 - 2005
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Littman Lecturer VA Boston Healthcare System, 29th Annual David Littman Memorial Lecture, 2012
  • Distinguished Physician Award American Association of Cardiologists of Indian Origin, 2006
  • Gulf South Medical Education Foundation Award Gulf South Medical Education Foundation, 2006
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Characteristics Associated with High-Performing Pediatric Heart Transplant Centers in the United States from 2006 to 2015  
    Mandeep Mehra, MD, JAMA Network Open
  • Redefining Left Ventricular Assist Device Indications and Strategies—Reply  
    Mandeep Mehra, MD, JAMA Cardiology
  • Untimely Trial Publication A Sin of Omission?  
    Mandeep Mehra, MD, JACC: Cardiovascular Imaging
  • Join now to see all

Lectures

  • Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with HeartMate 3 (MOMENTUM 3): Final Analysis of the 1028 Patient ... 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
  • Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with HeartMate 3 (MOMENTUM 3): Final Analysis of the 1028 Patient ... 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019

Authored Content

  • Untimely Trial Publication A Sin of Omission?June 2020
  • Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19May 2020
  • Emerging Trends in Financing of Adult Heart Transplantation in the United StatesJanuary 2019

Press Mentions

  • FDA Approves Elimination of Aspirin Use in HeartMate 3 LVAD Patients
    FDA Approves Elimination of Aspirin Use in HeartMate 3 LVAD PatientsAugust 23rd, 2024
  • No Aspirin, No Problem: FDA Approves Key Update for Abbott Heart Pumps
    No Aspirin, No Problem: FDA Approves Key Update for Abbott Heart PumpsAugust 21st, 2024
  • Published Findings Highlight Tecarfarin's Potential and Reinforce Need for Better Anticoagulation Therapy in LVAD Patients
    Published Findings Highlight Tecarfarin's Potential and Reinforce Need for Better Anticoagulation Therapy in LVAD PatientsAugust 20th, 2024
  • Join now to see all

Professional Memberships

Other Languages

  • Hindi, Urdu